Piper Sandler lowered the firm’s price target on Incyte to $85 from $90 and keeps an Overweight rating on the shares. The firm notes the Q3 top-line print was underwhelming across the board, though Piper notes that some of the Jakafi weakness was not unexpected due to previously articulated quarter-over-quarter inventory dynamics, and it models a Q4 rebound.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on INCY: